Show simple item record

dc.contributor.authorSahin, Sezgin
dc.contributor.authorKASAPÇOPUR, Özgür
dc.contributor.authorADROVIC YILDIZ, Amra
dc.contributor.authorBARUT, Kenan
dc.contributor.authorCokugras, Haluk
dc.contributor.authorKILINÇ, Ayşe Ayzıt
dc.contributor.authorOnal, Pinar
dc.contributor.authorOztosun, Berrak
dc.contributor.authorYildiz, Mehmet
dc.identifier.citationKILINÇ A. A. , Onal P., Oztosun B., Yildiz M., ADROVIC YILDIZ A., Sahin S., BARUT K., Cokugras H., KASAPÇOPUR Ö., "Determination of tuberculin skin test for isoniazid prophylaxis in BCG vaccinated children who are using anti-TNF agents for rheumatologic diseases", PEDIATRIC PULMONOLOGY, cilt.55, sa.10, ss.2689-2696, 2020
dc.description.abstractObjective The use of tumor necrosis factor inhibitors (anti-TNF) has a risk of activating latent tuberculosis infection (LTBI). This study was performed to investigate LTBI according to tuberculin skin test (TST) size and to determine the frequency of tuberculosis (TB) in bacillus Calmette-Guerin (BCG)-vaccinated children receiving anti-TNF treatment for rheumatological disease. Materials and Methods The study consisted of 559 children. Information on demographics, anti-TNF agents, TST size, and isoniazid (INH) prophylaxis was recorded. Patients (n = 254) with TST size >= 5 mm were divided into three groups according to TST size and INH prophylaxis: group 1, TST size 5 to 9 mm and no INH prophylaxis; group 2, TST size 5 to 9 mm with INH prophylaxis; and group 3, TST size >= 10 mm with INH prophylaxis. Results The 559 patients comprised 314 (56.3%) females and 245 (43.6%) males; they had a mean age of 13.1 +/- 4.1 years. The mean TST size in all patients was 4.2 +/- 4.7 mm. Group 1 consisted of 76 (29.9%) patients, group 2 consisted of 88 (34.6%) patients, and group 3 consisted of 90 (35.4%) patients. The mean TST sizes for the three groups were 6.8 +/- 3.1 mm, 7.2 +/- 3.2 mm, and 13.9 +/- 2.8 mm, respectively. New TB was diagnosed in only two (0.35%) patients. Both of them were in group 3. Conclusions A TST size of >= 10 mm in BCG-vaccinated children receiving anti-TNF treatment may distinguish children at high risk for reactivation of LTBI.
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleDetermination of tuberculin skin test for isoniazid prophylaxis in BCG vaccinated children who are using anti-TNF agents for rheumatologic diseases
dc.relation.journalPEDIATRIC PULMONOLOGY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record